WASHINGTON – Today, the United States House of Representatives Energy and Commerce Committee unveiled its FDA User Fee legislative package, which did not include the burdensome and dangerous “mandatory product listing” concept in its legislation to reauthorize FDA user fees for drugs, biologics, and medical devices.
“The NPA applauds Chairman Frank Pallone and Republican Leader Cathy McMorris Rodgers for resisting the puzzling and misguided desire from some industry associations to hit the companies they claim to represent with the ‘double whammy’ of new regulatory obstacles stifling innovation and adding to higher costs,” said Daniel Fabricant, Ph.D. president and CEO of the Natural Products Association.
“NPA hopes the Senate Health, Education, Labor, and Pensions Committee (HELP) will also reject proposals like the Durbin-Braun bill, which would create unnecessary premarket bureaucracy in the name of transparency while undermining the carefully crafted Bioterrorism Act provisions that keep sensitive product and manufacturing information out of the hands of malicious individuals.”
NPA has been extensively lobbying against “mandatory product listing” for dietary supplements and the corresponding U.S. Senate bill S. 4090, introduced by Senators Dick Durbin and Mike Braun. NPA has also launched a grassroots campaign, which can be viewed here, where tens of thousands of health and wellness advocates have already written their members of Congress urging they oppose S.4090.
